Benjamin Jackson

Stock Analyst at Jefferies

(n/a)

# 4,933

Out of 5,182 analysts

2

Total ratings

n/a

Success rate

-12.72%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Benjamin Jackson

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GMAB Genmab	Reinstates: Buy	$42	$27.52	+50.80%	1	Feb 17, 2026
	EVO Evotec SE	Downgrades: Hold	$8.7 → $3.8	$3.20	+18.75%	1	Oct 7, 2024

Genmab

Feb 17, 2026

Reinstates: Buy

Price Target: $42

Current: $27.52

Upside: +50.80%

Evotec SE

Oct 7, 2024

Downgrades: Hold

Price Target: $8.7 → $3.8

Current: $3.20

Upside: +18.75%